Keynote Speakers
Peter Quesenberry Professor of Medicine, The Warren Alpert Medical School of Brown University |
Steve Soper Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas |
Tony Jun Huang William Bevan Distinguished Professor of Mechanical Engineering and Materials Science, Duke University |
David Wong Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles |
Jan Lötvall Professor Krefting Research Centre, University of Gothenburg, Chief Scientist, Codiak BioSciences; Founding President of ISEV |
George Calin Professor and The Alan M. Gewirtz Leukemia & Lymphoma Society Scholar, University of Texas MD Anderson Cancer Center |
|
Mike Makrigiorgos Professor of Radiation Oncology, Dana Farber Cancer Institute and Harvard Medical School |
J. Carl Barrett Vice President, Translational Sciences Oncology, AstraZeneca |
Cheng-Ho Jimmy Lin Chief Scientific Officer, Oncology, Natera |
Lucia Languino Professor of Cancer Biology, Thomas Jefferson University |
Daniel Chiu A. Bruce Montgomery Professor of Chemistry, University of Washington |
Paul Robbins Professor, Department of Biochemistry, Molecular Biology, and Biophysics, and the Institute on the Biology of Aging and Metabolism, University of Minnesota Medical School |
Y. Peng Loh Chief and Senior Investigator, Section on Cellular Neurobiology, Eunice Kennedy Shriver National Institute of Child health and Human Development, National Institutes of Health (NIH) |
Gyongyi Szabo Professor & Vice Chair for Research, Department of Medicine, University of Massachusetts Medical School |
Anindya Dutta Harry F. Byrd Professor and Chair of Biochemistry and Molecular Genetics and Professor of Pathology, University of Virginia School of Medicine |
Balaji Panchapakesan Professor, Department of Mechanical Engineering, Worcester Polytechnic Institute (WPI) |
Shannon Stott Assistant Professor, Massachusetts General Hospital & Harvard Medical School |
Walter Koch Vice President, Roche Molecular Systems |
Steven Pirie-Shepherd Director, Pfizer |
Bob Carter Professor and Chief of Neurosurgery, Massachusetts General Hospital, Harvard Medical School |
Jennifer Jones NIH Stadtman Investigator, Head of Transnational Nanobiology, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute |
OverviewSelect Biosciences Fifth Annual Circulating Biomarkers World Congress 2018 brings together the most up-to-date technologies and advances in this expanding and evolving field. Our coverage in this conference focuses on the various classes of circulating biomarkers and their emerging applications: - Extracellular Vesicles (EVs): Exosomes and Microvesicles
- Circulating Nucleic Acids: Circulating Cell-Free DNA, Circulating RNAs
- Circulating Cells in the Circulation (Circulating Tumor Cells and Cancer Stem Cells)
This conference features an international faculty of speakers from academia as well as industry addressing the following topic areas: - Technologies for Isolation and Characterization: Single Vesicle Analysis Approaches
- Role in Cancer and Various Disease Classes
- Biomarker Potential for Diagnostics Development
- Therapeutics Potential and Technology Advances in the EV Field
Registered delegates receive access to the co-located concurrent conference tracks, the co-located exhibit hall featuring companies from around the world providing tools/technologies, products and services addressing the circulating biomarkers field. QIAGEN Dinner Workshop to Registered Delegates Entitled "Cutting Edge NGS Workflows for Liquid Biopsy."Information and Local Registration Facilities for this Conference are also available in:
Japanese
|
Korean
|
Chinese (Simplified)
|
Chinese (Traditional)
Agenda and Information for:
|
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|